logo

Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.
newsletter@anandascientific.com
+1234567890
 

Bioavailability

The Science Behind It All...

Bioavailability

INNOVATION AND ACCOMPLISHMENT

ANANDA Scientific is resolving a long-standing problem that restricts the dependable and cost-efficient use of cannabinoids as medicine. The Company has distinctively pursued a science-based approach to create cannabinoid products that are highly bioavailable when consumed by mouth and thus can efficiently get into the bloodstream – for the first time. Its advent portends consistent dosing and predictable therapeutic outcomes.

ANANDA Scientific centers its current activities on a particular non-psychoactive cannabinoid, cannabidiol (“CBD”). CBD occurs in hemp, a Cannabis plant containing such minuscule amounts of tetrahydrocannabinol (THC) that it cannot be used for “getting high” or, in other words, it has no abuse potential. Hemp is grown around the world for its nutritious seeds and oils, along with fiber for textiles and building materials.

In addition, ANANDA Scientific has developed proprietary hemp strains with extraordinary levels of CBD that permit extraction and purification to proceed in a very cost-effective fashion.

Hemp is an important source of CBD and, in the opinion of many healthcare professionals, CBD is the most important cannabinoid from a medicinal perspective. It manifests enticing potential as a therapy for treating many intractable, debilitating and life-threatening conditions. It also appears remarkably safe to use.

Factors Decreasing Bioavailability

INCREASING BIOSYNTHESIS

When taken by mouth, cannabinoid entry into the body is erratic. As little as 4% of an oral dose reaches the bloodstream — too little to be reproducibly and therapeutically useful. ANANDA Scientific is successfully addressing this critical issue by proprietarily making cannabinoids, particularly CBD, bioavailable at unprecedented high levels by employing novel and patent-protected ANANDA Particulate Technology™.

For the first time, cannabinoids can be economically, precisely and reproducibly delivered into the bloodstream via mouth. This advance centers about combining cannabinoids with proprietary ANANDA Particulate Technology™ made with GRAS chemistry. “GRAS” is the United States government designation for substances that are Generally Recognized as Safe, (i.e., safe for human use). Using ANANDA Particulate Technology™ with CBD dramatically increases the potency for a given dose and a more rapid time-to-effect (minutes, not hours like others).

Given its important, proprietary technological advances and necessary evidence-based perspective, ANANDA Scientific is poised to deliver the benefits of CBD and other cannabinoids. The size of the prospective market for cannabinoid therapies, especially those involving CBD, represents an important opportunity to reduce suffering and save lives worldwide.

graph (1)

Best Evidence Supports the Non-Psychoative Cannabinoid CBD as the Key Agent for Therapeutic use.

More than 3000 scientific and medical works point to the non-psychoactive cannabinoid, CBD as overwhelmingly important for better human health.

  • CBD has an incredibly desirable safety profile, no side effects of consequence known
  • The non-psychoactivity of CBD permits normal activities (work, school, sports, driving) and eliminates abuse liability.